PBAX   $5.2  6.75% Market Closed

Phoenix Biotech Acquisition Corp
Total Cash 119.01K
totalCashPerShare 0.019
EBITDA
Total Debt 1.40M
quickRatio 0.025
currentRatio 1.764
Total Revenue
debtToEquity
Revenue/Share
ROA -0.02548
ROE
grossProfits
freeCashflow -7.95M
operatingCashflow -1.71M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 37.82M
forwardPE
floatShares 940.12K
sharesOutstanding 6.23M
sharesShort 757.00
sharesShortPriorMonth 2.87K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.95%
heldPercentInstitutions 0.15%
Short Ratio help_outline 0.79%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue -2.204
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -2.52M
trailingEps -0.35%
forwardEps
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 10
lastUpdated April 1, 2024, 3:42 p.m.